ID | Age | Gender | Treatment duration | Antiviral treatment | Possible transmission | GPT IU/ml | Genotype | HLA A,B |
---|---|---|---|---|---|---|---|---|
1 | 57 | m | Week 38-93 | Peg-interferon/ribavirin | Unknown | 1181 | 1b | A2,A3,B7,Bw6 |
2 | 38 | m | None | None | Sexual | 1996 | 1b | A2,A26,B15,B51 |
3 | 63 | m | Week5-31 | Peg-interferon | Unknown | 616 | 1b | A1,A2,B7,B8 |
4 | 46 | f | Week2-28 | peg-interferon | Medical | 647 | 1b | A1,A2,B4,B51 |